hidrad

FDA approves Novartis Cosentyx as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade
Yahoo Finance
Wed, 11/1/23 - 10:14 pm
Novartis
Cosentyx
FDA
hidrad
Fresh from IPO, Acelyrin's lead drug fails clinical trial
Pharmaphorum
Tue, 09/12/23 - 12:02 pm
Acelyrin
clinical trials
izokibep
hidrad